NIH-funded research
Investigation of reconstructive outcomes and clinically meaningful questions.
Research & innovation
As an Assistant Professor-in-Residence at UCLA, NIH-funded investigator, and FDA advisor, Dr. DeLong studies questions that shape reconstructive outcomes, breast-implant safety, and medical-device regulation.
Academic medicine
Dr. DeLong is an active NIH-funded researcher whose work focuses on cancer and breast reconstruction outcomes, breast-implant safety, and medical-device regulatory science. He completed a fellowship at the FDA Center for Devices and Radiological Health and has served as a voting member of the FDA General and Plastic Surgery Devices Panel.
He also built a 95-site quality improvement program for breast reconstruction, bringing shared measurement and learning to reconstructive care across participating sites.
His academic service includes manuscript review for multiple journals.
Investigation of reconstructive outcomes and clinically meaningful questions.
Training in device regulation and service on a federal advisory panel.
Research on breast implants, reconstruction materials, and device science.
Built a 95-site quality improvement program for breast reconstruction.
Best Breast Paper (2020) and Bernard G. Sarnat Award (2019).
Selected publications